{"id":"W2948772049","doi":"10.1200/jco.2019.37.18_suppl.lba2","title":"Overall survival (OS) results of a phase III randomized trial of standard-of-care therapy with or without enzalutamide for metastatic hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led international cooperative group trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Ottawa Hospital","funders":"","keywords":"Enzalutamide; Medicine; Docetaxel; Oncology; Internal medicine; Clinical endpoint; Prostate cancer; Hazard ratio; Cancer; Androgen receptor; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004409866,0.001664168,0.001593401,0.0004208967,0.0004023184,0.0009395916,0.001027881,0.001400164,0.005941021],"category_scores_gemma":[0.002779346,0.0004761231,0.002112895,0.0004092839,0.001101073,0.0009187038,0.0005870887,0.003108331,0.0007648432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009841856,"about_ca_system_score_gemma":0.001075228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009997117,"about_ca_topic_score_gemma":0.002608692,"domain_scores_codex":[0.9984134,0.001149272,0.0000564513,0.0001597477,0.00007235817,0.0001487944],"domain_scores_gemma":[0.9982901,0.0004806538,0.0004322295,0.0001659501,0.00009183618,0.0005391971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9819866,0.003710487,0.001321187,0.0002398825,0.001050433,0.00002401065,0.00003932772,0.0005266393,0.001084408,0.00006990967,0.00134442,0.008602633],"study_design_scores_gemma":[0.9034355,0.08735585,0.005780299,0.00003325506,0.001341705,0.00004566161,0.00002247758,0.0004335431,0.0003856519,0.0002125232,0.0009392597,0.0000143267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856442,0.003500888,0.0005421616,0.0007956824,0.0003415904,0.002395406,0.003006724,0.00009462903,0.003678782],"genre_scores_gemma":[0.9856303,0.001178094,0.001196977,0.001007712,0.0002915848,0.003730622,0.004127152,0.00003356375,0.002803923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005941021,"threshold_uncertainty_score":0.02332187,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1237783978815783,"score_gpt":0.5153794555294441,"score_spread":0.3916010576478658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}